Trial intelligence / Profile preview

hCRF for Peritumoral Brain Edema

NCT00691522Phase 2Terminated

Sponsor
PharmaNet Development Group
Start
Nov 2008
Primary completion
Aug 2009
Modality
Peptides, Recombinant Proteins and Enzymes
01

Overview

A Phase 2 trial of corticorelin ovine triflutate in Peritumoral brain edema (PTBE), sponsored by PharmaNet Development Group. Started Nov 2008; status: terminated.

02

Drugs

corticorelin ovine triflutate
03

Conditions

Peritumoral brain edema (PTBE)

Beyond the preview

Go deeper on NCT00691522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00691522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call